Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length

Journal of Immunotherapy

Volumn 30, Issue 1, 2007, Pages 123-129

  Shen, Xinglei ^a   Zhou, Juhua ^a   Hathcock, Karen S ^a   Robbins, Paul ^a   Powell Jr , Daniel J ^a   Rosenberg, Steven A ^a   Hodes, Richard J ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer; Immunotherapy; Telomerase; Telomere

Indexed keywords

INTERLEUKIN 2; TELOMERASE;

ADOPTIVE IMMUNOTHERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURGERY; CELL PROLIFERATION; CHROMOSOME SIZE; CLONAL VARIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG MEGADOSE; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; SENESCENCE; STIMULATION; T LYMPHOCYTE; TELOMERE; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION;

HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 33846028221     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cji.0000211321.07654.b8     Document Type: Article

References (33)

1. Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346.
2. Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850.
3. Dudley M, Mark E, Wunderlich JR, et al. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26:332.
4. Robbins PF, Dudley ME, Wunderlich J, et al. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol. 2004;173:7125.
5. Weng NP, Palmer LD, Levine BL, et al. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev. 1997;160:43.
6. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol. 2002;20:682.
7. Weng N, Levine B, June C, et al. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. PNAS. 1995;92:11091.
8. Blackburn E. Structure and function of telomeres. Nature. 1991;350:569.
9. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458.
10. Rufer N, Dragowska W, Thornbury G, et al. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743.
11. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005;579:859.
12. Hodes R, Richard J, Hathcock KS, et al. Telomeres in T and B cells. Nat Rev Immunol. 2002;2:699.
13. Effros RB, Dagarag M, Spaulding C, et al. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005;205:147.
14. Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106:661.
15. Zhou J, Shen X, Hodes RJ, et al. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J. Immunol. 2005;175:7046.
16. Zhou J, Dudley ME, Rosenberg SA, et al. Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma. J Immunol. 2004;173:7622.
17. Hathcock KS, Hodes RJ, Weng N-p. Analysis of telomere length and telomerase activity. In: Coligan JE, Kruisbeek AM, Margulies DH, et al, eds. Current Protocols in Immunology. New York: Greene Publishing Associates and Wiley-Interscience; 2004:10.30.1-27.
18. Plunkett FJ, Soares MV, Annels N, et al. The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection. Blood. 2001;97:700.
19. Baerlocher GM, Lansdorp PM. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell Biol. 2004;75:719.
20. Weng N, Levine B, June C, et al. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med. 1996;183:2471.
21. Maini MK, Soares MVD, Zilch CF, et al. Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J Immunol. 1999;162:4521.
22. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell. 1985;43:405.
23. Roth A, Yssel H, Pene J, et al. Telomerase levels control the lifespan of human T lymphocytes. Blood. 2003;102:849.
24. Reed JR, Vukmanovic-Stejic M, Fletcher JM, et al. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med. 2004;199:1433.
25. Wagner UG, Koetz K, Weyand CM, et al. Perturbation of the T cell repertoire in rheumatoid arthritis. PNAS. 1998;95:14447.
26. Migliaccio M, Amacker M, Just T, et al. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J Immunol. 2000;165:4978.
27. Perillo NL, Naeim F, Walford RL, et al. In vitro cellular aging in T-lymphocyte cultures: analysis of DNA content and cell size. Exp Cell Res. 1993;207:131.
28. Perillo NL, Naeim F, Walford RL, et al. In vitro cellular aging in T-lymphocyte cultures: analysis of DNA content and cell size. Exp Cell Res. 1993;207:131.
29. Li Y, Zhi W, Wareski P, et al. IL-15 activates telomerase and minimizes telomere loss and may preserve the replicative life span of memory CD8+ T cells in vitro. J Immunol. 2005;174:4019.
30. Soares MVD, Plunkett FJ, Verbeke CS, et al. Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection. Blood. 2004;103:162.
31. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349.
32. Rufer N, Migliaccio M, Antonchuk J, et al. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood. 2001;98:597.
33. Dagarag M, Evazyan T, Rao N, et al. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol. 2004;173:6303.